Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Bellerophon Therapeutics Q2 EPS $(0.43) Down From $(0.36) YoY

Bellerophon Therapeutics Q2 EPS $(0.43) Down From $(0.36) YoY

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(0.43) per share. This is a 19.44 percent decrease over losses of $(0.36) per share from the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(0.43) per share. This is a 19.44 percent decrease over losses of $(0.36) per share from the same period last year.

Lake Street Maintains Buy on Calavo Growers, Lowers Price Target to $38

By Benzinga Newsdesk

March 7, 10:25 AM

Lake Street analyst Ben Klieve maintains Calavo Growers (NASDAQ:CVGW) with a Buy and lowers the price target from $50 to $38.

CVGW

Earnings

How To Attend Roblox Q3 2022 Earnings Conference Call

By Benzinga Insights

October 26, 6:25 AM

Roblox (NYSE:RBLX) will host a conference call at 08:30 AM ET on November 9, 2022, to discuss Q3 2022 earnings results. How to Attend Roblox (RBLX) Conference Call Follow this link to access the live webcast.

RBLX

Why U Power (UCAR) Shares Are Surging Thursday

By Erica Kollmann

June 1, 11:00 AM

U Power Ltd. (NASDAQ: UCAR) shares are surging higher on Thursday after the company announced it has entered into a strategic cooperation agreement with Quantum Solutions Co in Japan. The Details:

UCAR